Autologous cell based gene therapy (Northern Therapeutics)

N/A

Report date: 2022/07/20 13:32:33

Base Information

Drug NameAutologous cell based gene therapy (Northern Therapeutics)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionNitric oxide synthase, inducible inhibitors
TargetsNitric oxide synthase, inducible
Therapy Area/IndicationsHypertension, Pulmonary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Toronto - St. George Campus
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNorthern Therapeutics
Active IndicationsN/A
Inactive IndicationsHypertension, Pulmonary

Other Information

ATC CodeN/A
Related LinksN/A